Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-12-12
2008-11-25
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253060, C514S253090, C514S253010, C544S121000, C544S360000, C544S363000, C544S364000
Reexamination Certificate
active
07456175
ABSTRACT:
The present invention relates to compounds of formula Iwherein R1, R2, X, Y, Z and m are as defined in the description and claims, and pharmaceutically acceptable salts thereof as well as to pharmaceutical composition comprising these compounds and to methods for their preparation. The compounds are useful for the treatment and/or prevention of diseases which are associated with the modulation of H3 receptors.
REFERENCES:
patent: 4910307 (1990-03-01), Wyatt
patent: 5075445 (1991-12-01), Jarvest et al.
patent: 2003/0236259 (2003-12-01), Hohlweg et al.
patent: 2004/0019039 (2004-01-01), Dorwald et al.
patent: 2006/0160809 (2006-07-01), Braje et al.
patent: 2007/0054918 (2007-03-01), Braje et al.
patent: 0 233 051 (1997-08-01), None
patent: 1156045 (2001-11-01), None
patent: WO 2004/089905 (2004-10-01), None
patent: 2005/011654 (2005-02-01), None
patent: 2006/058649 (2006-06-01), None
Phillips et al. Annual Reports in medicinal Chemistry, vol. 33,p. 31-40 (1998).
Passani et al. Neuroscience and Biobehavioral Reviews, vol. 24, p. 107-113 (2000).
Leurs et al. TIPS, vol. 19, p. 177-183 (1998).
Burks 1994 in Johnson L.R. ed., Physiology of the Gastrointestinal Tract, Raven Press, NY, pp. 211-242.
Leurs et al., Br J. Pharmacol. 1991, 102, pp. 179-185.
Raithel et al., Int. Arch. Allergy Immunol. 1995, 108, 127-133.
Panula et al., Proc. Natl. Acad. Sci. USA 1984, 81, 2572-2576.
Inagaki et al., J. Comp. Neurol 1988, 273, 283-300.
Arrang et al., Nature 1983, 302, 832-837.
Arrang et al., Neuroscience 1987, 23, 149-157.
Clapham & Kilpatrik, Br. J. Pharmacol. 1982, 107, 919-923.
Blandina et al. in The Histamine H3 Receptor (Leurs RL and Timmermann H eds, 1998, pp. 27-40, Elsevier, Amsterdam, The Netherlands.
Masaki et al; Endocrinol. 2003, 144, 2741-2748.
Hancock et al., European J. of Pharmacol. 2004, 487, 183-197.
Timmermann, J. Med. Chem. 1990, 33, 4-11.
Nettekoven Matthias Heinrich
Roche Olivier
Rodriguez-Sarmiento Rosa Maria
Bernhardt Emily
Hoffman-La Roche Inc.
Johnston George W.
Megerditchian Samuel H.
Tramaloni Dennis P.
LandOfFree
Piperazinyl-pyridine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazinyl-pyridine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazinyl-pyridine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4034814